Summary:
- This article provides a comprehensive review of the role of the NLRP3 inflammasome in the pathogenesis of autoimmune diseases, detailing its activation mechanisms and regulatory pathways.
- The research evaluates the therapeutic potential of targeting NLRP3-mediated signaling as a strategy for treating complex immune-mediated disorders, emphasizing the bridge between molecular immunology and clinical application.